Tribe, Generics Spar Over PTAB Amici In Allergan Patent Row
By Kyle Jahner ( December 18, 2017, 10:31 PM EST) -- Drug companies and native tribes traded responses Friday to a flood of amicus briefs as the Patent Trial and Appeal Board weighs whether sovereign immunity bars a challenge to a drug patent sold by Allergan Inc. to a Native American tribe in the middle of an inter partes review....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.